it was named niacin from the words "nicotinic acid vitamin.") Current guidelines recommend consideration of combination drug therapy to achieve optimal low-density LDL cholesterol lowering and ...

Results of the ARBITER 6–HALTS trial indicate a superiority of the lipid-modifying agent nicotinic acid over ezetimibe ... because of low levels of HDL cholesterol. But is the evidence ...

Low circulating levels of HDL cholesterol might ... Cholesteryl ester transfer protein inhibitors, nicotinic acid, reconstituted HDL and other HDL-raising agents are being investigated.